These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 25396144)

  • 1. Pentoxifylline and its applications in dermatology.
    Hassan I; Dorjay K; Anwar P
    Indian Dermatol Online J; 2014 Oct; 5(4):510-6. PubMed ID: 25396144
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pentoxifylline in dermatology.
    Balazic E; Axler E; Konisky H; Khanna U; Kobets K
    J Cosmet Dermatol; 2023 Feb; 22(2):410-417. PubMed ID: 36208009
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pentoxifylline use in dermatology.
    Çakmak SK; Çakmak A; Gönül M; Kiliç A; Gül Ü
    Inflamm Allergy Drug Targets; 2012 Dec; 11(6):422-32. PubMed ID: 22680624
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The xanthine derivative 1-(5'-oxohexyl)-3-methyl-7-propyl xanthine (HWA 285) enhances the actions of adenosine.
    Fredholm BB; Lindström K
    Acta Pharmacol Toxicol (Copenh); 1986 Mar; 58(3):187-92. PubMed ID: 3012941
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pentoxifylline, a methyl xanthine derivative, reduces peritoneal adhesions and increases peritoneal fibrinolysis in rats.
    Tarhan OR; Barut I; Sutcu R; Akdeniz Y; Akturk O
    Tohoku J Exp Med; 2006 Jul; 209(3):249-55. PubMed ID: 16778372
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pentoxifylline: a drug with wide spectrum applications in dermatology.
    Zargari O
    Dermatol Online J; 2008 Nov; 14(11):2. PubMed ID: 19094840
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A fatal case of suicidal pentoxifylline intoxication.
    Suárez-Peñaranda JM; Rico-Boquete R; López-Rivadulla M; Blanco-Pampín J; Concheiro-Carro L
    Int J Legal Med; 1998; 111(3):151-3. PubMed ID: 9587798
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Urinary excretion of pentoxifylline and its metabolites by standardbred mares.
    Kwong EC; Chen FC; Young LM
    Can J Vet Res; 1989 Apr; 53(2):147-53. PubMed ID: 2713780
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prolongation of pentoxifylline aliphatic side chain positively affects the reversal of P-glycoprotein-mediated multidrug resistance in L1210/VCR line cells.
    Docolomanský P; Fialová I; Barancík M; Rybár A; Breier A
    Gen Physiol Biophys; 2005 Dec; 24(4):461-6. PubMed ID: 16474189
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pentoxifylline for neonatal sepsis.
    Haque K; Mohan P
    Cochrane Database Syst Rev; 2003; (4):CD004205. PubMed ID: 14584009
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy of pentoxifylline in the management of microalbuminuria in patients with diabetes.
    Rodríguez-Morán M; Guerrero-Romero F
    Curr Diabetes Rev; 2008 Feb; 4(1):55-62. PubMed ID: 18220696
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effect of pentoxifylline on L-1 sarcoma tumor growth and angiogenesis in Balb/c mice.
    Bałan BJ; Demkow U; Skopiński P; Bychawska M; Skopińska-Różewska E; Lewicki S; Zdanowski R
    Cent Eur J Immunol; 2017; 42(2):131-139. PubMed ID: 28860931
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Xanthine interference with dipyridamole-thallium-201 myocardial imaging.
    Stanek EJ; Melko GP; Charland SL
    Ann Pharmacother; 1995 Apr; 29(4):425-7. PubMed ID: 7633022
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition cAMP-phosphodiesterase in the rat heart by pentoxifylline--a new xanthine derivative.
    Nandi JS; Nair KG; Deo S
    Adv Myocardiol; 1980; 1():359-65. PubMed ID: 6248939
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Amelioration of ischemia-reperfusion injury in rat intestine by pentoxifylline-mediated inhibition of xanthine oxidase.
    Hammerman C; Goldschmidt D; Caplan MS; Kaplan M; Schimmel MS; Eidelman AI; Branski D; Hochman A
    J Pediatr Gastroenterol Nutr; 1999 Jul; 29(1):69-74. PubMed ID: 10400107
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacology of pentoxifylline, a hemorheologic agent for the treatment of intermittent claudication.
    Aviado DM; Dettelbach HR
    Angiology; 1984 Jul; 35(7):407-17. PubMed ID: 6380349
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of pro-inflammatory cytokine gene expression and papilloma growth during murine multistage carcinogenesis by pentoxifylline.
    Robertson FM; Ross MS; Tober KL; Long BW; Oberyszyn TM
    Carcinogenesis; 1996 Aug; 17(8):1719-28. PubMed ID: 8761432
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Determination of 3,7-dimethyl-1-(5-oxohexyl)-xanthine (pentoxifylline) and its 3,7-dimethyl-1-(5-hydroxyhexyl)-xanthine metabolite in the plasma of patients with multiple diseases using high-performance liquid chromatography.
    Rieck W; Platt D
    J Chromatogr; 1984 Feb; 305(2):419-27. PubMed ID: 6707169
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of prostacyclin in the protective effects of pentoxifylline and other xanthine derivatives in endotoxin action in mice.
    Schade UF
    Eicosanoids; 1989; 2(3):183-8. PubMed ID: 2517031
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of pentoxifylline on kidney damage induced by nitrosamine in male rats.
    Jalili C; Moradi D; Roshankhah S; Salahshoor MR
    Res Pharm Sci; 2019 Feb; 14(1):64-73. PubMed ID: 30936934
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.